Author

Rob Aarnoutse

Observed names: Aarnoutse, Rob, Rob Aarnoutse (5123507)

Institutions: Radboud University Nijmegen, Radboud University Medical Center

Observed institutions: Radboud University Nijmegen, Radboud University Medical Center, Radboud Institute for Health Sciences

OpenAlex ID: A5113258748

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

2025 · Norbert Heinrich, Veronique de Jager, et al. · The Lancet Microbe · 30

Protein binding of rifampicin is not saturated when using high-dose rifampicin

2018 · Carlijn H C Litjens, Rob E Aarnoutse, et al. · Journal of Antimicrobial Chemotherapy · 21

The Effect of Real-Time Medication Monitoring-Based Digital Adherence Tools on Adherence to Antiretroviral Therapy and Viral Suppression in People Living With HIV: A Systematic Literature Review and Meta-Analysis

2024 · Takondwa Charles Msosa, Iraseni Swai, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 13

Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials

2023 · Emmanuel Musisi, Adam Wyness, et al. · The Lancet Microbe · 11

Influence of age and co‐medication on dolutegravir glucuronidation in paediatric patients

2024 · Tom G. Jacobs, Hylke Waalewijn, et al. · British Journal of Clinical Pharmacology · 2

A Digital Adherence Tools randomised trial among children living with HIV: lessons learnt

2026 · Iraseni Ufoo Swai, Takondwa Msosa, et al. · Research Square

Pharmacokinetics of minocycline with and without rifampicin co-administration in patients with nontuberculous mycobacterial disease

2026 · Arthur Lemson, Rob Aarnoutse, et al. · Journal of Antimicrobial Chemotherapy

Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity

2026 · Cynthia van Arkel, Ralf Stemkens, et al. · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Understanding ischemia in children with tuberculous meningitis (iThemba): a protocol paper

2026 · Carien Truter, Melissa S. Hamilton, et al. · BMC Pediatrics

Rifampicin leads to subtherapeutic azithromycin exposures in NTM disease treatment

2025 · Michael Rodgers, Victor Dahl, et al.

Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome

2013 · Patrick Phillips, Michael Hoelscher, et al. · Trials

Works count: 16

Citation count: 77

H-index: 4

I10-index: 4